Newsletter May 2021 No.203
Top News
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
On March 23, 2021, the "Pharmaceutical Manufacturers Association of Japan Press Conference" was held at the Nihonbashi Life Science Hub (Chuo-ku, Tokyo). The press conference was attended by 42 members of the media (22 at the venue and 20 watching via webcast), and questions were actively exchanged at the conference.
Topics
- The 32nd Pharmaceutical Manufacturers Association of Japan (PMAJ) Policy Seminar" Held Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era
- The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "32nd PMAJ Media Forum" under the theme of "What is a Vaccine? -In the wake of the Corona Disaster, learn about vaccines once again" - "2021 Life Science IP Policy Seminar
- The 2021 Life Science IP Forum was held, with the theme "How to Handle IP Rights in Response to Pandemics, Including COVID-19
- The theme was "Reconsidering the Diverse Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals.
- Held "FY2020 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice
- Held the FY2020 Compliance Managers and Practitioners Meeting.
Policy Research Institute page
From JPMA
From the "Pharmaceutical Association of Japan Press Conference